7月15日,中国生物制药(1177.HK)宣布一项重大交易:全额收购拉诺瓦医药。此次收购的对价上限设定在约9.5092亿美元。
7月15日,中国生物制药(1177.HK)宣布一项重大交易:全额收购拉诺瓦医药。此次收购的对价上限设定在约9.5092亿美元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.